Lv1
58 积分 2025-02-23 加入
Imatinib and the dawn of precision cancer therapy
2天前
已完结
Asciminib: the tyrosine kinase inhibitor with a unique mechanism of action
2天前
已完结
Integrated bioinformatics analysis to develop diagnostic models for malignant transformation of chronic proliferative diseases
2天前
已完结
AMPLIFY: A second-generation BTK inhibitor for fixed-duration therapy in chronic lymphocytic leukemia
2天前
求助中
Olverembatinib in chronic myeloid leukemia—Review of historical development, current status, and future research
6天前
已完结
HSR25-182: Patient-Physician Communication About Adverse Events and Impact on Quality of Life to Foster Shared Decision-Making in Chronic Myeloid Leukemia
9天前
已关闭
HSR25-174: Impact of Adverse Events on Quality of Life in Patients With Chronic Myeloid Leukemia Treated With Tyrosine Kinase Inhibitors – Results From the Survey on Humanistic Burden of Intolerance to First or Second TKIs (SHIFT) Study
9天前
已关闭
The present and future for CAR-T cell therapy in adult B-cell ALL
11天前
已完结
Incorporation of immunotherapy into frontline treatment for adults with B-cell precursor acute lymphoblastic leukemia
11天前
已完结
Classification and risk stratification in T-lineage acute lymphoblastic leukemia
11天前
已完结
皖公网安备34019202002308
